Daron Wells, a father of three and husband, has stage 4 lung cancer. He's now fighting his health insurance company for a ...

Daron Wells, a father of three and husband, has stage 4 lung cancer. He's now fighting his health insurance company for a ...

Lung Cancer Test Predicts Survival in Early Stages Better Than ... that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...

Predictors of longer postdiscontinuation progression-free survival include complete/partial response, longer treatment duration.

Targeting clonal antigens and circumventing dysfunctional states may be important for conferring clinical responses to TIL therapy.

Afatinib has broad activity against EGFR mutations. However, the approval for uncommon mutations was based on data from 38 ...

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.